In the context of B7–H6, knockdown of this checkpoint using siRNAs in glioma CSCs resulted in their hampered proliferation profile through downregulation of c-Myc and repressing RNA guanine-7 methyltransferase (RNMT) activity [31]. The gene discussed is RNMT; the disease is central nervous system cancer.